Nrg1β as a Proangiogenesis Therapy: How Is Nrg1β Therapy Unique from Other Angiogenesis Therapies?

Ying H. Shen, Jun Ichi Abe

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)2315-2317
Number of pages3
JournalArteriosclerosis, thrombosis, and vascular biology
StateAccepted/In press - 2021


  • angiogenesis
  • cardiomyopathy
  • Editorials
  • endothelium
  • hypoxia
  • inflammation
  • remote ischemic preconditioning

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this